Successful treatment of orbital rhabdomyosarcoma in two infants using chemotherapy alone

Med Pediatr Oncol. 1996 Mar;26(3):186-9. doi: 10.1002/(SICI)1096-911X(199603)26:3<186::AID-MPO7>3.0.CO;2-G.

Abstract

Two infants, 2 months and 13 months of age, were found to have orbital embryonal rhabdomyosarcomas (ERMS). Because of the adversities associated with either surgical exenteration or curative doses of radiation therapy, they were treated with chemotherapy alone. They survive disease-free 5 and 9 years after diagnosis with excellent cosmesis and normal vision. This approach may be suitable for similarly small (< 2 cm in diameter) ERMS in other sites.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Female
  • Follow-Up Studies
  • Humans
  • Infant
  • Male
  • Orbital Neoplasms / drug therapy*
  • Orbital Neoplasms / pathology
  • Rhabdomyosarcoma / drug therapy*
  • Rhabdomyosarcoma / pathology
  • Treatment Outcome